Periscope Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Periscope Capital’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-90,684	Closed	-$904K	–	1133
2022 Q3	$904K	Sell	90,684 -60,600	-40%	-$602K	0.03%	571
2022 Q2	$1.49M	Hold	151,284	–	–	0.04%	572
2022 Q1	$1.49M	Buy	151,284 +7,784	+5%	+$76.2K	0.04%	589
2021 Q4	$1.4M	Sell	143,500 -200	-0.1%	-$1.96K	0.04%	562
2021 Q3	$1.41M	Hold	143,700	–	–	0.04%	538
2021 Q2	$1.4M	Hold	143,700	–	–	0.05%	494
2021 Q1	$1.43M	Buy	+143,700	New	+$1.47M	0.06%	398

Periscope Capital's FLAC Position: Q4 2022 in Review

Periscope Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 90,684 shares — an estimated $904K sold.

Periscope Capital first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.49M in Q2 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Periscope Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Periscope Capital sold 90,684 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $904K.
Periscope Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Periscope Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.49M in Q2 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.